机译:用纳米结构脂质携带者共同递送Lumacafactor和IvaCafeaftor的囊性纤维化的吸入处理
Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;
Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;
Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;
Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;
Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;
Rutgers State Univ Ernest Mario Sch Pharm Dept Pharmaceut 160 Frelinghuysen Rd Piscataway NJ 08854 USA;
Fibrosis; Pulmonary delivery; Lipid nanoparticles; Imaging; Transgenic mice; Cystic fibrosis transmembrane receptor (CFTR);
机译:用纳米结构脂质携带者共同递送Lumacafactor和IvaCafeaftor的囊性纤维化的吸入处理
机译:洛米飞舵管与IVACAFTOR在患者患者囊性纤维化患者中的安全性和疗效
机译:LumacaFactor / Ivacafeaftor治疗开始后囊性纤维化患者呼出呼吸挥发性有机化合物的变化
机译:干粉吸入性噬菌体多聚颗粒减少肺囊性纤维化细菌感染
机译:克服基于纳米颗粒的基因载体的囊性纤维化痰障碍
机译:CFTR调制器治疗Lumacafactor / IVAcaftor在囊性纤维化患者中改变了血浆可溶性维生素A和E的血浆浓度
机译:Lumacafetor与Ivacafacter在患者囊性纤维化患者中的治疗安全性和疗效